SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-15-162309
Filing Date
2015-04-30
Accepted
2015-04-30 16:46:40
Documents
5
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d917300d10ka.htm 10-K/A 118770
2 EX-31.1 d917300dex311.htm EX-31.1 6187
3 EX-31.2 d917300dex312.htm EX-31.2 6185
4 EX-32.1 d917300dex321.htm EX-32.1 4090
5 GRAPHIC g917300g52u37.jpg GRAPHIC 109745
  Complete submission text file 0001193125-15-162309.txt   287799
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-24006 | Film No.: 15819576
SIC: 2834 Pharmaceutical Preparations